This Article Abstract Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Ellis, S. G. Articles by Stone, G. W. Search for Related Content PubMed Articles by Ellis, S. G. Articles by Stone, G. W.

Incidence, Timing, and Correlates of Stent Thrombosis With the Polymeric Paclitaxel Drug-Eluting Stent

A TAXUS II, IV, V, and VI Meta-Analysis of 3,445 Patients Followed for Up to 3 Years

Stephen G. Ellis, MD, FACC^_*,_*, Antonio Colombo, MD, FACC, Eberhard Grube, MD, FACC, Jeffrey Popma, MD, FACC, Joerg Koglin, MD, FACC^||, Keith D. Dawkins, MD, FACC^¶ and Gregg W. Stone, MD, FACC^#

^_* The Cleveland Clinic, Cleveland, Ohio
Columbus Hospital, Milan, Italy
Heart Center Siegburg, Siegburg, Germany
Brigham and Women's Hospital, Boston, Massachusetts
^|| Boston Scientific Corporation, Natick, Massachusetts
^¶ Southampton University Hospital, Southampton, United Kingdom
^# Columbia University Medical Center and the Cardiovascular Research Foundation, New York, New York

View larger version (24K): [in this window] [in a new window] [Download PPT slide]   Figure 1 Breakdown of Stent Thrombosis by Time and Type of Stent Received MR = moderate release; SR = slow release; ST = stent thrombosis.

View larger version (17K): [in this window] [in a new window] [Download PPT slide]   Figure 2 Freedom From Stent Thrombosis for Patients From TAXUS II, IV, V De Novo, and VI Shown is event-free survival ± 1.5 SEM for all patients (n = 3,445).